Lifecore Biomedical, Inc.

NasdaqGS:LFCR Stock Report

Market Cap: US$235.7m

Lifecore Biomedical Balance Sheet Health

Financial Health criteria checks 1/6

Lifecore Biomedical has a total shareholder equity of $39.5M and total debt of $127.9M, which brings its debt-to-equity ratio to 323.8%. Its total assets and total liabilities are $246.8M and $207.3M respectively.

Key information

323.8%

Debt to equity ratio

US$127.92m

Debt

Interest coverage ration/a
CashUS$5.52m
EquityUS$39.50m
Total liabilitiesUS$207.32m
Total assetsUS$246.82m

Recent financial health updates

Recent updates

Lifecore Biomedical: Finally A 'Pure Play' CDMO Business

Nov 12

Lifecore Biomedical: No Sale Soon Amidst Leverage And Uncertainty

Jun 24

White Falcon Capital - Lifecore Biomedical: Potential For Rapid Growth In Earnings And FCF Surge

Apr 20

Would Lifecore Biomedical (NASDAQ:LFCR) Be Better Off With Less Debt?

Jun 30
Would Lifecore Biomedical (NASDAQ:LFCR) Be Better Off With Less Debt?

Landec Non-GAAP EPS of -$0.32, revenue of $43.35M

Oct 06

Landec receives Nasdaq's notification on delayed annual report filing

Sep 09

Laughing Water Capital - Landec Corp. : A High Quality CDMO

Jul 27

Landec (NASDAQ:LNDC) Takes On Some Risk With Its Use Of Debt

Jun 24
Landec (NASDAQ:LNDC) Takes On Some Risk With Its Use Of Debt

Analysts Have Been Trimming Their Landec Corporation (NASDAQ:LNDC) Price Target After Its Latest Report

Apr 08
Analysts Have Been Trimming Their Landec Corporation (NASDAQ:LNDC) Price Target After Its Latest Report

Landec (NASDAQ:LNDC) Has A Somewhat Strained Balance Sheet

Mar 21
Landec (NASDAQ:LNDC) Has A Somewhat Strained Balance Sheet

Here's What's Concerning About Landec's (NASDAQ:LNDC) Returns On Capital

Nov 30
Here's What's Concerning About Landec's (NASDAQ:LNDC) Returns On Capital

Optimistic About Landec's Strategic Initiatives And Sodium Hyaluronate Products

Nov 05

Financial Position Analysis

Short Term Liabilities: LFCR's short term assets ($74.2M) exceed its short term liabilities ($40.5M).

Long Term Liabilities: LFCR's short term assets ($74.2M) do not cover its long term liabilities ($166.8M).


Debt to Equity History and Analysis

Debt Level: LFCR's net debt to equity ratio (309.9%) is considered high.

Reducing Debt: LFCR's debt to equity ratio has increased from 62.7% to 323.8% over the past 5 years.

Debt Coverage: LFCR's debt is not well covered by operating cash flow (5.8%).

Interest Coverage: Insufficient data to determine if LFCR's interest payments on its debt are well covered by EBIT.


Balance Sheet


Discover healthy companies